BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37855183)

  • 1. Strong OLIG2 expression in supratentorial ependymoma, ZFTA fusion-positive: A potential diagnostic pitfall.
    de Castro JVA; Kulikowski LD; Wolff BM; Natalino R; Carraro DM; Torrezan GT; Scapulatempo Neto C; Amancio CT; Canedo FSNA; Feher O; Costa FD
    Neuropathology; 2024 Apr; 44(2):167-172. PubMed ID: 37855183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supratentorial non-RELA, ZFTA-fused ependymomas: a comprehensive phenotype genotype correlation highlighting the number of zinc fingers in ZFTA-NCOA1/2 fusions.
    Tauziède-Espariat A; Siegfried A; Nicaise Y; Kergrohen T; Sievers P; Vasiljevic A; Roux A; Dezamis E; Benevello C; Machet MC; Michalak S; Puiseux C; Llamas-Gutierrez F; Leblond P; Bourdeaut F; Grill J; Dufour C; Guerrini-Rousseau L; Abbou S; Dangouloff-Ros V; Boddaert N; Saffroy R; Hasty L; Wahler E; Pagès M; Andreiuolo F; Lechapt E; Chrétien F; Blauwblomme T; Beccaria K; Pallud J; Puget S; Uro-Coste E; Varlet P;
    Acta Neuropathol Commun; 2021 Aug; 9(1):135. PubMed ID: 34389065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostics of pediatric supratentorial RELA ependymomas: integration of information from histopathology, genetics, DNA methylation and imaging.
    Pagès M; Pajtler KW; Puget S; Castel D; Boddaert N; Tauziède-Espariat A; Picot S; Debily MA; Kool M; Capper D; Sainte-Rose C; Chrétien F; Pfister SM; Pietsch T; Grill J; Varlet P; Andreiuolo F
    Brain Pathol; 2019 May; 29(3):325-335. PubMed ID: 30325077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L1CAM Immunopositivity in Anaplastic Supratentorial Ependymomas: Correlation With Clinical and Histological Parameters.
    Chavali P; Rao S; Palavalasa S; Bevinahalli N; Muthane YTC; Sadashiva N; Santosh V
    Int J Surg Pathol; 2019 May; 27(3):251-258. PubMed ID: 30251576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumors.
    Fukuoka K; Kanemura Y; Shofuda T; Fukushima S; Yamashita S; Narushima D; Kato M; Honda-Kitahara M; Ichikawa H; Kohno T; Sasaki A; Hirato J; Hirose T; Komori T; Satomi K; Yoshida A; Yamasaki K; Nakano Y; Takada A; Nakamura T; Takami H; Matsushita Y; Suzuki T; Nakamura H; Makino K; Sonoda Y; Saito R; Tominaga T; Matsusaka Y; Kobayashi K; Nagane M; Furuta T; Nakada M; Narita Y; Hirose Y; Ohba S; Wada A; Shimizu K; Kurozumi K; Date I; Fukai J; Miyairi Y; Kagawa N; Kawamura A; Yoshida M; Nishida N; Wataya T; Yamaoka M; Tsuyuguchi N; Uda T; Takahashi M; Nakano Y; Akai T; Izumoto S; Nonaka M; Yoshifuji K; Kodama Y; Mano M; Ozawa T; Ramaswamy V; Taylor MD; Ushijima T; Shibui S; Yamasaki M; Arai H; Sakamoto H; Nishikawa R; Ichimura K;
    Acta Neuropathol Commun; 2018 Dec; 6(1):134. PubMed ID: 30514397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel type of C11orf95-LOC-RELA fusion in a grade II supratentorial ependymoma: report of a case with literature review.
    de Sousa GR; Marie SKN; Oba-Shinjo SM; Ramalho LNZ; Tone LG; Valera ET
    Childs Nerv Syst; 2019 Apr; 35(4):689-694. PubMed ID: 30631904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Immunohistochemistry in the Identification of Supratentorial C11ORF95-RELA Fused Ependymoma in Routine Neuropathology.
    Gessi M; Giagnacovo M; Modena P; Elefante G; Gianno F; Buttarelli FR; Arcella A; Donofrio V; Diomedi Camassei F; Nozza P; Morra I; Massimino M; Pollo B; Giangaspero F; Antonelli M
    Am J Surg Pathol; 2019 Jan; 43(1):56-63. PubMed ID: 29266023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI Phenotype of RELA-fused Pediatric Supratentorial Ependymoma.
    Nowak J; Jünger ST; Huflage H; Seidel C; Hohm A; Vandergrift LA; von Hoff K; Rutkowski S; Pietsch T; Warmuth-Metz M
    Clin Neuroradiol; 2019 Dec; 29(4):595-604. PubMed ID: 30027327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encouraging option of multi-staged gross total resection for a C11orf-RelA fusion-positive supratentorial anaplastic ependymoma.
    Nakamura T; Fukuoka K; Ikeda J; Yoshitomi M; Udaka N; Tanoshima R; Tateishi K; Yamanaka S; Ichimura K; Yamamoto T
    Brain Tumor Pathol; 2017 Oct; 34(4):160-164. PubMed ID: 28831588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific expression of PD-L1 in RELA-fusion supratentorial ependymoma: Implications for PD-1-targeted therapy.
    Witt DA; Donson AM; Amani V; Moreira DC; Sanford B; Hoffman LM; Handler MH; Levy JMM; Jones KL; Nellan A; Foreman NK; Griesinger AM
    Pediatr Blood Cancer; 2018 May; 65(5):e26960. PubMed ID: 29350470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular subgrouping of ependymoma across three anatomic sites and their prognostic implications.
    Chinnam D; Gupta K; Kiran T; Saraswati A; Salunke P; Madan R; Kumar N; Radotra BD
    Brain Tumor Pathol; 2022 Jul; 39(3):151-161. PubMed ID: 35348910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-Species Genomics Reveals Oncogenic Dependencies in ZFTA/C11orf95 Fusion-Positive Supratentorial Ependymomas.
    Zheng T; Ghasemi DR; Okonechnikov K; Korshunov A; Sill M; Maass KK; Benites Goncalves da Silva P; Ryzhova M; Gojo J; Stichel D; Arabzade A; Kupp R; Benzel J; Taya S; Adachi T; Shiraishi R; Gerber NU; Sturm D; Ecker J; Sievers P; Selt F; Chapman R; Haberler C; Figarella-Branger D; Reifenberger G; Fleischhack G; Rutkowski S; Donson AM; Ramaswamy V; Capper D; Ellison DW; Herold-Mende CC; Schüller U; Brandner S; Driever PH; Kros JM; Snuderl M; Milde T; Grundy RG; Hoshino M; Mack SC; Gilbertson RJ; Jones DTW; Kool M; von Deimling A; Pfister SM; Sahm F; Kawauchi D; Pajtler KW
    Cancer Discov; 2021 Sep; 11(9):2230-2247. PubMed ID: 33879448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZFTA-RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma.
    Arabzade A; Zhao Y; Varadharajan S; Chen HC; Jessa S; Rivas B; Stuckert AJ; Solis M; Kardian A; Tlais D; Golbourn BJ; Stanton AJ; Chan YS; Olson C; Karlin KL; Kong K; Kupp R; Hu B; Injac SG; Ngo M; Wang PR; De León LA; Sahm F; Kawauchi D; Pfister SM; Lin CY; Hodges HC; Singh I; Westbrook TF; Chintagumpala MM; Blaney SM; Parsons DW; Pajtler KW; Agnihotri S; Gilbertson RJ; Yi J; Jabado N; Kleinman CL; Bertrand KC; Deneen B; Mack SC
    Cancer Discov; 2021 Sep; 11(9):2200-2215. PubMed ID: 33741710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. epi-Aszonalenin B from Aspergillus novofumigatus inhibits NF-κB activity induced by ZFTA-RELA fusion protein that drives ependymoma.
    Ishikawa K; Ishii M; Yaguchi T; Katada T; Ichinose K; Ohata S
    Biochem Biophys Res Commun; 2022 Mar; 596():104-110. PubMed ID: 35131506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional profiling of paediatric ependymomas identifies prognostically significant groups.
    Łastowska M; Matyja E; Sobocińska A; Wojtaś B; Niemira M; Szałkowska A; Krętowski A; Karkucińska-Więckowska A; Kaleta M; Ejmont M; Tarasińska M; Perek-Polnik M; Dembowska-Bagińska B; Pronicki M; Grajkowska W; Trubicka J
    J Pathol Clin Res; 2021 Nov; 7(6):565-576. PubMed ID: 34314101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ependymoma-like tumor with mesenchymal differentiation harboring C11orf95-NCOA1/2 or -RELA fusion: A hitherto unclassified tumor related to ependymoma.
    Tomomasa R; Arai Y; Kawabata-Iwakawa R; Fukuoka K; Nakano Y; Hama N; Nakata S; Suzuki N; Ishi Y; Tanaka S; Takahashi JA; Yuba Y; Shiota M; Natsume A; Kurimoto M; Shiba Y; Aoki M; Nabeshima K; Enomoto T; Inoue T; Fujimura J; Kondo A; Yao T; Okura N; Hirose T; Sasaki A; Nishiyama M; Ichimura K; Shibata T; Hirato J; Yokoo H; Nobusawa S
    Brain Pathol; 2021 May; 31(3):e12943. PubMed ID: 33576087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supratentorial ependymoma in childhood: more than just RELA or YAP.
    Zschernack V; Jünger ST; Mynarek M; Rutkowski S; Garre ML; Ebinger M; Neu M; Faber J; Erdlenbruch B; Claviez A; Bielack S; Brozou T; Frühwald MC; Dörner E; Dreschmann V; Stock A; Solymosi L; Hench J; Frank S; Vokuhl C; Waha A; Andreiuolo F; Pietsch T
    Acta Neuropathol; 2021 Mar; 141(3):455-466. PubMed ID: 33481105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CNS tumors with PLAGL1-fusion: beyond ZFTA and YAP1 in the genetic spectrum of supratentorial ependymomas.
    Tauziède-Espariat A; Nicaise Y; Sievers P; Sahm F; von Deimling A; Guillemot D; Pierron G; Duchesne M; Edjlali M; Dangouloff-Ros V; Boddaert N; Roux A; Dezamis E; Hasty L; Lhermitte B; Hirsch E; Hirsch MPV; Ardellier FD; Karnoub MA; Csanyi M; Maurage CA; Mokhtari K; Bielle F; Rigau V; Roujeau T; Abad M; Klein S; Bernier M; Horodyckid C; Adam C; Brandal P; Niehusmann P; Vannod-Michel Q; Provost C; de Champfleur NM; Nichelli L; Métais A; Mariet C; Chrétien F; Blauwblomme T; Beccaria K; Pallud J; Puget S; Uro-Coste E; Varlet P;
    Acta Neuropathol Commun; 2024 Apr; 12(1):55. PubMed ID: 38581034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RELA fusion-positive ependymoma accompanied by extensive desmoplasia: a case report.
    Fukushima T; Ueda T; Hirato J; Kataoka H
    Brain Tumor Pathol; 2020 Oct; 37(4):159-164. PubMed ID: 32754892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supratentorial extra-axial RELA fusion-positive ependymoma misdiagnosed as meningioma by intraoperative histological and cytological examinations: a case report.
    Nagayasu MA; Fukushima T; Matsumoto F; Takeshima H; Sato Y; Kataoka H
    J Med Case Rep; 2022 Aug; 16(1):312. PubMed ID: 35986385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.